250 related articles for article (PubMed ID: 28091735)
21. Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infection.
Topp SK; Rosenfeldt V; Vestergaard H; Christiansen CB; Von Linstow ML
Infect Dis (Lond); 2015; 47(12):908-14. PubMed ID: 26308113
[TBL] [Abstract][Full Text] [Related]
22. Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection.
Okano M; Gross TG
Am J Med Sci; 2012 Jun; 343(6):483-9. PubMed ID: 22104426
[TBL] [Abstract][Full Text] [Related]
23. Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection.
Maeda A; Wakiguchi H; Yokoyama W; Hisakawa H; Tomoda T; Kurashige T
J Infect Dis; 1999 Apr; 179(4):1012-5. PubMed ID: 10068600
[TBL] [Abstract][Full Text] [Related]
24. Cross-reactivity influences changes in human influenza A virus and Epstein Barr virus specific CD8 memory T cell receptor alpha and beta repertoires between young and old.
Clark F; Gil A; Thapa I; Aslan N; Ghersi D; Selin LK
Front Immunol; 2022; 13():1011935. PubMed ID: 36923729
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
26. Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases.
Hatta K; Morimoto A; Ishii E; Kimura H; Ueda I; Hibi S; Todo S; Sugimoto T; Imashuku S
Haematologica; 2007 Nov; 92(11):1470-4. PubMed ID: 18024394
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
28. Comparison of lymphocyte subpopulations in the peripheral blood of patients with infectious mononucleosis and human immunodeficiency virus infection: a preliminary report.
Zidovec S; Culig Z; Begovac J; Jeren T
J Clin Lab Immunol; 1998; 50(2):63-9. PubMed ID: 10470624
[TBL] [Abstract][Full Text] [Related]
29. Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases.
Lu G; Xie ZD; Zhao SY; Ye LJ; Wu RH; Liu CY; Yang S; Jin YK; Shen KL
Chin Med J (Engl); 2009 Feb; 122(3):262-6. PubMed ID: 19236801
[TBL] [Abstract][Full Text] [Related]
30. Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection.
Qian J; Yu Q; Chen G; Wang M; Zhao Z; Zhang Y; Qiu L
Clin Exp Med; 2020 Aug; 20(3):373-380. PubMed ID: 32206927
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
Yachie A; Kanegane H; Kasahara Y
Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
[TBL] [Abstract][Full Text] [Related]
32. Haematological associations of Epstein-Barr virus infection.
Okano M
Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):199-214. PubMed ID: 10942621
[TBL] [Abstract][Full Text] [Related]
33. Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies.
Kanegane H; Nomura K; Miyawaki T; Tosato G
Crit Rev Oncol Hematol; 2002 Dec; 44(3):239-49. PubMed ID: 12467964
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV.
Venturini C; Houldcroft CJ; Lazareva A; Wegner F; Morfopoulou S; Amrolia PJ; Golwala Z; Rao A; Marks SD; Simmonds J; Yoshikawa T; Farrell PJ; Cohen JI; Worth AJ; Breuer J
Br J Haematol; 2021 Oct; 195(2):249-255. PubMed ID: 34431085
[TBL] [Abstract][Full Text] [Related]
35. T cell-mediated immunity during Epstein-Barr virus infections in children.
Liu M; Wang R; Xie Z
Infect Genet Evol; 2023 Aug; 112():105443. PubMed ID: 37201619
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
37. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease.
Ohga S; Kimura N; Takada H; Nagano M; Ohshima K; Nomura A; Muraoka K; Take H; Yamamori S; Hara T
Am J Hematol; 1999 May; 61(1):26-33. PubMed ID: 10331508
[TBL] [Abstract][Full Text] [Related]
38. Flow Cytometry as the Tool to Define Peripheral Blood Leukocyte Signatures in Acute EBV Infection.
Singh P; Gadgeel M; AlQanber B; Farooqi A; Savaşan S
Cells; 2024 Jun; 13(11):. PubMed ID: 38891094
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of Epstein-Barr virus infection in Japanese children: a pictorial essay.
Moritani T; Aihara T; Oguma E; Shimanuki Y; Oishi T; Hanada R
Clin Imaging; 2001; 25(1):1-8. PubMed ID: 11435030
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic
Tanita K; Hoshino A; Imadome KI; Kamiya T; Inoue K; Okano T; Yeh TW; Yanagimachi M; Shiraishi A; Ishimura M; Schober T; Rohlfs M; Takagi M; Imai K; Takada H; Ohga S; Klein C; Morio T; Kanegane H
Front Pediatr; 2019; 7():15. PubMed ID: 30778380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
